Neurology
410 articles · 22 journals
Journals in this subcategory (22)
- Epilepsy Research · Elsevier (68)
- Journal of Clinical Neuroscience · Elsevier (68)
- Journal of the Neurological Sciences · Elsevier (67)
- The Journal of Pain · Elsevier (64)
- Ageing Research Reviews · Elsevier (62)
- Alcohol · Elsevier (29)
- Journal of Neuroimmunology · Elsevier (23)
- Brain Disorders · Elsevier (13)
- Spinal Cord · Springer Nature (8)
- Spinal Cord Series and Cases · Springer Nature (8)
- Acta Epileptologica · Springer Nature (0)
- Brain Imaging and Behavior · Springer Nature (0)
- Chinese Neurosurgical Journal · Springer Nature (0)
- Fluids and Barriers of the CNS · Springer Nature (0)
- Journal of Clinical Sleep Medicine · Springer Nature (0)
- Journal of Neuro-Oncology · Springer Nature (0)
- Journal of Neuro-Oncology Discovery · Springer Nature (0)
- Journal of Neuroinflammation · Springer Nature (0)
- Neurology and Therapy · Springer Nature (0)
- Sleep and Biological Rhythms · Springer Nature (0)
- Sleep and Vigilance · Springer Nature (0)
- npj Parkinson's Disease · Springer Nature (0)
- Comment on “Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease”
- Reply to “Interpreting the incremental prognostic value of admission laboratory tests in aneurysmal subarachnoid hemorrhage”
- Reply to: From cytokine discrimination to penetrance prediction in moyamoya disease: Comment on Park et al.
- Reply to: Comment on “Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease”
- From cytokine discrimination to penetrance prediction in moyamoya disease: Comment on Park et al.
- Reply to the Editor "Endovascular therapy for mild-to-moderate stroke due to basilar artery occlusion: Interpreting the certainty of excellent functional recovery"
- Evaluating LLM-based prognostication in intracerebral hemorrhage: Prompting and clinician benchmarking
- The authors reply to: Evaluating LLM-based prognostication in intracerebral hemorrhage: prompting and clinician benchmarking
- Comment on “Integrated determinants of multiple sclerosis susceptibility: Genetics, environment, infection and the microbiota”
- Psychosocial impacts of post-acute sequelae of COVID-19: insights from a longitudinal cohort
- Describing the pre-moyamoya stage: Lesion distribution, disease progression, and the impact of RNF213
- Evaluating metformin efficacy in ALS using real-world data: A causal inference approach
- Time for functional complement biomarkers in generalized Myasthenia Gravis
- Response to the comment on “A potential biomarker for the efficacy of complement inhibitors in myasthenia gravis”
- Post-herpes simplex virus autoimmune encephalitis with NMDAR and Septin-7 autoantibodies
- Hyperinsulinemia contributes to regulatory T-cell dysfunction and disease activity in multiple sclerosis
- Editorial overview: The microbiota–gut–brain axis in neuroimmunology: From molecular dialogue to therapeutic evidence
- Intranasal Chandipura virus infection reveals age- and strain-dependent differences in CNS and lethal encephalitis in mice
- Clinical utility of cerebrospinal fluid MOG-IgG testing in patients with paired serum and CSF testing
- Clinical characteristics and outcomes of autoimmune GFAP Astrocytopathy with concurrent CSF Epstein-Barr virus detection
- Olesoxime improves motor function and reduces neuronal injury in an ischemic stroke model by attenuating oxidative stress
- Multiple sclerosis: Advances in diagnosis, biomarkers, and disease management
- NOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD
- Co-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review
- Reassessment of a four-gene NK-cell-lineage-associated prognostic score in histologically defined grade 3 glioma
- Haginin A suppresses oxidative stress and pro-inflammatory mediators via MAPK and inflammasome regulation in LPS-stimulated microglia
- Cognitive level and rate of change in relapsing and progressive multiple sclerosis: a single-center retrospective cohort study in Japan
- Altered HMGB1–TLR4–NF-κB Signaling and regulatory microRNA expression in idiopathic generalized epilepsy according to Toxoplasma gondii serostatus
- Post-COVID neurological manifestations are associated with neuroinflammation, increased autoantibody burden, and persistent complement activation
- Anti-neuronal cell-surface antibodies in patients diagnosed with Parkinson-like disorders